期刊文献+

年龄相关性黄斑变性的预防 被引量:4

Prevention of age-related macular degene-ration
下载PDF
导出
摘要 年龄相关性黄斑变性在发达国家已是致盲原因之一,尽管目前有抗VEGF药物、激光、光动力学等湿性黄斑变性的治疗方法,但治疗效果有限。因此,目前最经济实惠的是黄斑变性的预防。我们对目前有据可依的一些黄斑变性的预防方法进行综述,包括4个方面:(1)合理膳食:维生素C、叶黄素、玉米黄素和脂肪酸等;(2)生活方式的管理,例如:戒烟和体重管理;(3)减少光照暴露,如太阳眼镜及滤波人工晶状体;(4)早期筛查。 Age-related macular degeneration(AMD) is one of the leading causes of blindness in the developed world.Although effective treatment modalities such as anti-VEGF,laser therapy,and photodynamic therapy have been developed for neovascular AMD,there is still no effective treatment for geographical atrophy,and therefore the most cost-effective management of AMD is to start with prevention.This review looks at current evidence on preventive measures targeted at AMD.Modalities reviewed include(1) nutritional supplements such as the Age-Related Eye Disease Study(AREDS) formula,lutein and zeaxanthin,omega-3 fatty acid,and berry extracts;(2) lifestyle modifications,including smoking and body-mass-index;(3) filtering sunlight,i.e.sunglasses and blue-blocking intraocular lenses,and(4) screening test.
作者 银娟萍 彭惠
出处 《国际眼科杂志》 CAS 2012年第2期271-273,共3页 International Eye Science
关键词 年龄相关性黄斑变性 预防 抗氧化 age-related macular degeneration prevention antioxidant
  • 相关文献

参考文献31

  • 1Snellen EL,Verbeek AL,Van Den Hoogen GW,et al.Neovascular age-related macular degeneration and its relationship to antioxidant intake.Acta Ophthalmol Scand2002;80(4):368-371.
  • 2Ian Yat Hin Wong,Simon Chi Yan Koo,Clement Wai Nang Chan.Prevention of age-related macular degeneration.Int Ophthalmol2011;31(1):73-82.
  • 3Rosenthal JM,Kim J,Monastario F,et al.Dose-ranging study of lutein supplementation in persons aged 60 years or older.Invest Ophthalmol Vis Sci2006;47(12):5227-5233.
  • 4Whitehead AJ,Mares JA,Danis RP.Macular pigment:a review of current knowledge.Arch Ophthalmol2006;124(7):1038-1045.
  • 5Moeller SM,Parekh N,Tinker L.CAREDS Research Study Group.Associations between intermediate age-related macular degeneration and lutein and zeaxanthin in the Carotenoids in Age-Related Eye Disease Study(CAREDS):ancillary study of the Women's Health Initiative.Arch Ophthalmol2006;124(8):1151-1162.
  • 6Delcourt C,Carrière I,Delage M,et al.the POLA Study Group.Plasma lutein and zeaxanthin and other carotenoids as modifiable risk factors for age-related maculopathy and cataract:the POLA study.Invest Ophthalmol Vis Sci2006;47(6):2329-2335.
  • 7Gale CR,Hall NF,Phillips DI,et al.Lutein and zeaxanthin status and risk of age-related macular degeneration.Invest Ophthalmol Vis Sci2003;44(6):2461-2465.
  • 8Mozaffarian D,Rimm EB.Fish intake,contaminants,and human health:evaluating the risks and the benefits.JAMA2006;296(15):1885-1899.
  • 9Seddon JM,Gensler G,Milton RC,et al.Association between Creactive protein and age-related macular degeneration.JAMA2004;291(6):704-710.
  • 10Edwards AO,Ritter R,Abel KJ,et al.Complement factor H polymorphism and age-related macular degeneration.Science2005;308(5720):421-424.

同被引文献68

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部